Episode

Episode 420: Long-Term Myelodysplastic Syndrome Considerations for Oncology Nurses

Podcast
The ONS Podcast
Published
Jun 19, 2026
Duration seconds
2584
Processing state
not_requested
Canonical source
https://onsvoice.libsyn.com/episode-420-long-term-myelodysplastic-syndrome-considerations-for-oncology-nurses
Audio
https://traffic.libsyn.com/secure/onsvoice/420_Long_Term_MDS_Considerations_mixdown.mp3?dest-id=557038
JSON
/v1/public/podcasts/the-ons-podcast-1126448/episodes/episode-420-long-term-myelodysplastic-syndrome-considerations-for-oncology-nurses
Markdown
/podcast/the-ons-podcast-1126448/episode-420-long-term-myelodysplastic-syndrome-considerations-for-oncology-nurses.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-ons-podcast-1126448/episodes/episode-420-long-term-myelodysplastic-syndrome-considerations-for-oncology-nurses/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-ons-podcast-1126448/episode-420-long-term-myelodysplastic-syndrome-considerations-for-oncology-nurses.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

"We typically think of the disease progressing for our higher-risk patients because many of them already start with increased blasts or a lot of dysplasia. And they have these chromosomal variants that make them prone to evolving into acute myeloid leukemia (AML). With them, we can anticipate that they are going to progress to AML. And that's what we're trying to prevent. It's kind of like a biologic evolution and not a switch," ONS member Sara Tinsley-Vance, PhD, APRN, AOCN ® , nurse practitioner and quality-of-life researcher at Moffitt Cancer Center in Tampa, FL, told Lenise Taylor, MN, RN, AOCNS ® , TCTCN ™ , oncology clinical specialist at ONS, during a conversation about long-term myelodysplastic syndrome (MDS) considerations for oncology nurses. Music Credit: " Fireflies and Stardust " by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 19, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to management of long-term side effects related to myelodysplastic syndrome and its treatment. Episode Notes Complete this evaluation for free NCPD . ONS Podcast ™ episodes: Episode 415: Myelodysplastic Syndrome Treatment Considerations for Oncology Nurses Episode 411: An Overview of Myelodysplastic Syndrome for Oncology Nurses Episode 256: Cancer Symptom Management Basics: Hematologic Complicatio…